Stock Events

Stock Events

Lotus Pharmaceuticals 

$0
6
-$0-31.3% Friday 13:30

Statistics

Day High
0
Day Low
0
52W High
0.01
52W Low
0
Volume
10,000
Avg. Volume
10,313
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

10NovExpected
Q4 2009
Q1 2010
Q3 2010
Q4 2010
Q1 2011
Q2 2011
Q3 2011
-0.13
-0
0.12
0.25
Expected EPS
N/A
Actual EPS
0.04

Financials

-Profit Margin
Unprofitable
2019
2021
2022
2023
0Revenue
-19,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LTUS. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is a global healthcare company that produces pharmaceuticals competitive with Lotus Pharmaceuticals' offerings, particularly in therapeutic areas.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. is a direct competitor in the pharmaceutical industry, developing and marketing drugs that may overlap with Lotus Pharmaceuticals' product lines.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the pharmaceutical sector with a broad range of products that could compete across several of Lotus Pharmaceuticals' key areas.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline plc is a British multinational pharmaceutical company that competes in various therapeutic areas with Lotus Pharmaceuticals.
Novartis
NVS
Mkt Cap237.61B
Novartis AG is a Swiss multinational pharmaceutical company that produces drugs in direct competition with Lotus Pharmaceuticals, especially in the European market.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie Inc. is known for its innovative pharmaceuticals that could rival Lotus Pharmaceuticals' products, especially in specialty therapeutic areas.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb Company offers a range of prescription pharmaceuticals in areas that could compete with Lotus Pharmaceuticals' portfolio.
Sanofi
SNY
Mkt Cap124.45B
Sanofi is a French multinational pharmaceutical company that competes globally with Lotus Pharmaceuticals, particularly in vaccines and chronic disease treatments.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG is a Swiss multinational healthcare company that competes with Lotus Pharmaceuticals in the development and marketing of pharmaceuticals.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca PLC is a British-Swedish multinational pharmaceutical and biopharmaceutical company that competes in areas like oncology, which may overlap with Lotus Pharmaceuticals' interests.

About

Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China. The company is based in Nashville, Tennessee.
Show more...
CEO
Dr. Zhong Yi Liu
Employees
233
Country
US
ISIN
US5457152032

Listings

OTC Link
US
LTUS

0 Comments

Share your thoughts

FAQ

What is Lotus Pharmaceuticals stock price today?▼
The current price of LTUS is $0 USD — it has decreased by -31.3% in the past 24 hours. Watch Lotus Pharmaceuticals stock price performance more closely on the chart.
What is Lotus Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Lotus Pharmaceuticals stocks are traded under the ticker LTUS.
What were Lotus Pharmaceuticals earnings last quarter?▼
LTUS earnings for the last quarter are 0.04 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Lotus Pharmaceuticals revenue for the last year?▼
Lotus Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Lotus Pharmaceuticals net income for the last year?▼
LTUS net income for the last year is -19,000 USD.
How many employees does Lotus Pharmaceuticals have?▼
As of April 02, 2026, the company has 233 employees.
In which sector is Lotus Pharmaceuticals located?▼
Lotus Pharmaceuticals operates in the Health Care sector.
When did Lotus Pharmaceuticals complete a stock split?▼
The last stock split for Lotus Pharmaceuticals was on December 31, 2010 with a ratio of 1:2.
Where is Lotus Pharmaceuticals headquartered?▼
Lotus Pharmaceuticals is headquartered in Nashville, US.